Vanguard Group
OSCR icon

Vanguard Group’s Oscar Health OSCR Stock Holding History

Vanguard Group’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$297M Buy
20,701,250
+540,851
+3% +$9.36M ﹤0.01% 1339
2025
Q3 		$382M Buy
20,160,399
+423,184
+2% +$6.97M 0.01% 1214
2025
Q2 		$423M Buy
19,737,215
+38,773
+0.2% +$576K 0.01% 1120
2025
Q1 		$258M Buy
19,698,442
+700,469
+4% +$10.4M ﹤0.01% 1352
2024
Q4 		$255M Buy
18,997,973
+586,626
+3% +$9.44M ﹤0.01% 1425
2024
Q3 		$391M Buy
18,411,347
+1,026,676
+6% +$18.5M 0.01% 1185
2024
Q2 		$275M Buy
17,384,671
+2,801,909
+19% +$51.5M 0.01% 1317
2024
Q1 		$217M Buy
14,582,762
+337,850
+2% +$4.63M ﹤0.01% 1467
2023
Q4 		$130M Buy
14,244,912
+116,978
+0.8% +$807K ﹤0.01% 1723
2023
Q3 		$78.7M Buy
14,127,934
+2,211,743
+19% +$15.5M ﹤0.01% 1929
2023
Q2 		$96M Buy
11,916,191
+161,214
+1% +$1.19M ﹤0.01% 1880
2023
Q1 		$76.9M Buy
11,754,977
+299,277
+3% +$1.22M ﹤0.01% 1953
2022
Q4 		$28.2M Buy
11,455,700
+240,020
+2% +$750K ﹤0.01% 2473
2022
Q3 		$56M Buy
11,215,680
+1,329,461
+13% +$7.76M ﹤0.01% 2126
2022
Q2 		$42M Buy
9,886,219
+897,615
+10% +$5.71M ﹤0.01% 2276
2022
Q1 		$89.6M Sell
8,988,604
-310,603
-3% -$2.31M ﹤0.01% 2005
2021
Q4 		$73M Buy
9,299,207
+5,736,569
+161% +$72M ﹤0.01% 2142
2021
Q3 		$62M Sell
3,562,638
-21,482
-0.6% -$364K ﹤0.01% 2238
2021
Q2 		$77.1M Buy
3,584,120
+719,400
+25% +$17.2M ﹤0.01% 2132
2021
Q1 		$77M Buy
+2,864,720
New +$89.7M ﹤0.01% 2090

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group's OSCR Position: Q4 2025 in Review

Vanguard Group increased its Oscar Health (OSCR) stake by 2.7% in Q4 2025, buying an estimated $9.36M and bringing the position to 20,701,250 shares worth $297M. The position accounts for ﹤0.01% of the portfolio, ranked #1339.

Vanguard Group first reported a position in OSCR in Q1 2021 and has held it in 20 quarters since. The position peaked at $423M in Q2 2025. 343 funds tracked by Wall St. Rank hold OSCR as of Q4 2025.

  • Vanguard Group held 20,701,250 shares of Oscar Health worth $297M as of Q4 2025.
  • Vanguard Group bought 540,851 Oscar Health shares in Q4 2025, an estimated $9.36M.
  • Oscar Health made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1339 holding.
  • Vanguard Group first reported a position in Oscar Health in Q1 2021 and has held it in 20 quarters since.
  • Vanguard Group's Oscar Health position peaked at $423M in Q2 2025.
  • 343 funds tracked by Wall St. Rank held Oscar Health as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.